HCPCS drug code · CMS crosswalk
Everolimus J-Code / HCPCS Code
In short
Everolimus is billed under HCPCS J7527 — Everolimus, oral, 0.25 mg. One billing unit is 0.25 mg. CMS's crosswalk lists 23 Everolimus NDCs under this code.
Reference
- J7527
- Everolimus, oral, 0.25 mgBilling unit: 0.25 mg
- Labelers
- Ascend Laboratories, LLC; Biocon Pharma Inc; Breckenridge Pharmaceutical, Inc.; Endo USA, Inc.; Hikma Pharmaceuticals USA Inc.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Everolimus units and claim line
Enter the dose given to get the J7527 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Everolimus NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00054-0470-21 | J7527 | Hikma Pharmaceuticals USA Inc. | 60 | 60 |
| 00054-0471-21 | J7527 | Hikma Pharmaceuticals USA Inc. | 60 | 120 |
| 00054-0472-21 | J7527 | Hikma Pharmaceuticals USA Inc. | 60 | 180 |
| 49884-0158-02 | J7527 | Endo USA, Inc. | 60 | 60 |
| 49884-0159-02 | J7527 | Endo USA, Inc. | 60 | 120 |
| 49884-0160-02 | J7527 | Endo USA, Inc. | 60 | 180 |
| 49884-0283-02 | J7527 | Endo USA, Inc. | 60 | 240 |
| 51991-0379-06 | J7527 | Breckenridge Pharmaceutical, Inc. | 60 | 60 |
| 51991-0379-60 | J7527 | Breckenridge Pharmaceutical, Inc. | 60 | 60 |
| 51991-0380-06 | J7527 | Breckenridge Pharmaceutical, Inc. | 60 | 120 |
| 51991-0380-60 | J7527 | Breckenridge Pharmaceutical, Inc. | 60 | 120 |
| 51991-0381-06 | J7527 | Breckenridge Pharmaceutical, Inc. | 60 | 180 |
| 51991-0381-60 | J7527 | Breckenridge Pharmaceutical, Inc. | 60 | 180 |
| 51991-0985-06 | J7527 | Breckenridge Pharmaceutical, Inc. | 60 | 240 |
| 51991-0985-60 | J7527 | Breckenridge Pharmaceutical, Inc. | 60 | 240 |
| 67877-0718-31 | J7527 | Ascend Laboratories, LLC | 60 | 60 |
| 67877-0719-31 | J7527 | Ascend Laboratories, LLC | 60 | 120 |
| 67877-0720-31 | J7527 | Ascend Laboratories, LLC | 60 | 180 |
| 67877-0721-31 | J7527 | Ascend Laboratories, LLC | 60 | 240 |
| 70377-0069-11 | J7527 | Biocon Pharma Inc | 60 | 60 |
| 70377-0070-11 | J7527 | Biocon Pharma Inc | 60 | 120 |
| 70377-0071-11 | J7527 | Biocon Pharma Inc | 60 | 180 |
| 70377-0112-11 | J7527 | Biocon Pharma Inc | 60 | 240 |
Everolimus: common questions
- What is the J-code for Everolimus?
- Everolimus is billed under HCPCS J7527 — Everolimus, oral, 0.25 mg. One billing unit is 0.25 mg. CMS's crosswalk lists 23 Everolimus NDCs under this code.
- How many J7527 billing units are in a package of Everolimus?
- CMS lists 60 to 240 billing units per package, depending on the NDC, where one unit is 0.25 mg. Units to report are based on the dose given, not the package.
- Is J7527 a CPT code?
- No. J7527 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.